Literature DB >> 467516

Tetrahydronorharmane modulates the depolarisation-induced efflux of 5-hydroxytryptamine and dopamine and is released by high potassium concentration from rat brain slices.

H Rommelspacher, N Subramanian.   

Abstract

Tetrahydronorharmane (THN), a compound which occurs in man and in rats is supposed to act as a modulator of 5-hydroxytryptaminergic neurones. It is reported here that THN stimulated the potassium-induced release of the neurotransmitter from brain slices. This suggests enhancement of the efflux as a mechanism for the 5-hydroxytryptamine-like action of THN in pharmacological experiments. Furthermore, THN decreased the potassium-evoked efflux of (3H)-dopamine. This is consistent with the inhibition of dopaminergic neurones by THN as seen previously in various in vivo experiments. Finally it is demonstrated that a high concentration of potassium evokes the efflux of (14C)-THN from brain slices. This finding suggests that THN is taken up into neurones and exerts its modulating action on serotonergic neurones either inside or outside the cell.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 467516     DOI: 10.1016/0014-2999(79)90436-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Brain serotonin and 5-hydroxyindoleacetic acid concentrations and serotonin synthesis following tetrahydro-beta-carboline administration in mice.

Authors:  N S Buckholtz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

2.  5-HT, dopamine, norepinephrine, and related metabolites in brain of low alcohol drinking (LAD) rats shift after chronic intra-hippocampal infusion of harman.

Authors:  A Adell; R D Myers
Journal:  Neurochem Res       Date:  1995-02       Impact factor: 3.996

Review 3.  Isoquinolines, beta-carbolines and alcohol drinking: involvement of opioid and dopaminergic mechanisms.

Authors:  R D Myers
Journal:  Experientia       Date:  1989-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.